Phosphoinositide 3-kinase in health and disease Volume 1
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
| Institution som forfatter: | |
|---|---|
| Andre forfattere: | , , |
| Format: | Electronic Resource |
| Sprog: | English |
| Udgivet: |
Berlin, Heidelberg
Springer
2011.
|
| Serier: | Current Topics in Microbiology and Immunology
346 |
| Fag: | |
| Online adgang: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |


